Global Regulatory Reach Lachman operates with FDA, EMA, HPRA, and MHRA across a global client base, serving emerging to enterprise firms worldwide. Sales opportunity: target companies expanding regulatory footprints, needing audits, quality system improvements, and comprehensive regulatory strategy services.

Mid Market Focus With 51-200 employees and revenue in the hundreds of millions, Lachman targets mid market pharma, biotech, and medical device players for scalable QA, regulatory affairs, data integrity, training, and systems evaluation solutions that support growth and global compliance.

Digital Inspection Capabilities Early adoption of remote inspections via Virtual Touring and emphasis on AI and digital oversight demonstrates a capability to support remote audits, virtual inspections, and digital compliance analytics—appealing to clients seeking efficiency and resilience.

Thought Leadership Footprint Regular presence at TIDES USA, PDA Week, and Global Pharmaceutical Quality Summit signals strong industry visibility. Sales teams can leverage events for co marketing, partner ecosystems, and inbound leads from attendees seeking regulatory strategy and submissions expertise.

Regulatory Tech Advantage Lachman's technology enabled offerings for regulatory submissions and compliance problem resolution suggest opportunities to upsell automation, data integrity solutions, systems evaluation, and training to accelerate submissions and maintain regulatory readiness.